GPR55 and myeloid sarcoma: When considering the total number of CB2R-GPR55 heteromers by assessing the number of red dots per cell, data analysis demonstrated higher expression in the GM of the prefrontal cortex compared to the WM, both in the control and MS patient samples (F1,572 = 4.63; p < 0.05) (Figure 2B).